GlassScriptPhysician profile
Jonathan D Rouse
NPI 1003250556
$20,152.04
in general payments reported to CMS, 2019-2025
24 companies · $1,990 in 2025
The $1,990 reported for 2025 was more than what 83% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $436 · 2020: $253 · 2021: $2,875 · 2022: $3,823 · 2023: $7,474 · 2024: $3,301 · 2025: $1,990.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,031 · Travel and Lodging: $5,735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,030.99 |
| Travel and Lodging | $5,734.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $15,924.21 | 2019-2025 | Viaflow, Hoffmann, Ortholoc 2 Lapifuse |
| Treace Medical Concepts, INC. | $1,673.45 | 2022 | |
| Smith+Nephew, INC. | $835.59 | 2022-2025 | Collagenase Santyl, Grafix Pl, Stravix |
| Organogenesis INC. | $490.68 | 2021-2025 | Puraply Wound Matrix |
| Medical Device Business Services, INC. | $302.99 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $222.34 | 2022-2023 | |
| Averitas Pharma INC. | $91.57 | 2023-2025 | Qutenza |
| Kerecis Limited | $83.98 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Integra Lifesciences Corporation | $80.91 | 2022-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Paratek Pharmaceuticals, INC. | $61.69 | 2021-2024 | Nuzyra |
| Orpyx Medical Technologies US INC. | $53.38 | 2023 | Orpyx Si |
| Next Science LLC | $46.71 | 2024 | Blastx, Xperience, Surgx |
| Innovation Technologies INC | $42.80 | 2022-2024 | Irrisept |
| Horizon Therapeutics Plc | $31.27 | 2020-2022 | |
| Advanced Oxygen Therapy INC. | $28.68 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $26.60 | 2024 | Novosorb Btm |
| Kci USA, INC. | $26.38 | 2022 | |
| Conetic Solutions, INC. | $24.46 | 2020 | |
| Orthofix Medical, INC. | $20.16 | 2025 | Accelstim |
| Baudax Bio INC. | $19.42 | 2021 | |
| Grt US Holding, INC. | $19.14 | 2022 | |
| Solventum Corporation | $16.19 | 2025 | Activ.A.C. |
| Pacira Pharmaceuticals Incorporated | $15.82 | 2024 | Exparel |
| Zimmer Biomet Holdings, INC. | $13.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Rouse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.